Acute phase IL-10 plasma concentration associates with the high risk sources of cardiogenic stroke

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Arponen, Otso ^a,b   Muuronen, Antti ^a,b   Taina, Mikko ^a   Sipola, Petri ^a,b   Hedman, Marja ^a   Jäkälä, Pekka ^a,b   Vanninen, Ritva ^a,b   Pulkki, Kari ^b,c   Mustonen, Pirjo ^d  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c OK Kuopio   (Finland)

^d Central Finland Health Care District   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; BLOOD LEVEL; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CARDIOEMBOLISM; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; EMBOLISM; FEMALE; FOLLOW UP; HEART INFARCTION; HOLTER MONITORING; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL ATRIAL FIBRILLATION; PROSPECTIVE STUDY; RISK ASSESSMENT; VERTEBRAL ARTERY; AGED; BLOOD; BRAIN EMBOLISM; COMPLICATION; MIDDLE AGED; RISK FACTOR; STROKE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; HUMANS; INTERLEUKIN-10; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84928787441     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120910     Document Type: Article

References (40)

1. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nature Reviews. Neuroscience. 2003; 4:399-415. PMID: 12728267
2. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global burden of disease study. Lancet. 1997; 349(9061):1269-1276. PMID: 9142060
3. Yip P, Jeng J, Lee T, Chang Y, Huang Z, Ng ZS, et al. Subtypes of ischemic stroke. A hospital-based stroke registry in Taiwan (SCAN-IV). Stroke. 1997; 28(12):2507-2512. PMID: 9412641
4. Ferro JM. Cardioembolic stroke: An update. Lancet Neurology. 2003; 2(3):177-188.
5. D'Olhaberriague L, Hernández-Vidal A, Molina L, Soler-Singla L, Marrugat J, Pons S, et al. A prospective study of atrial fibrillation and stroke. Stroke. 1989; 20(12):1648-1652. PMID: 2688196
6. Bang OY, Lee PH, Joo SY, Lee JS, Joo IS, Huh K. Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Annals of Neurology. 2003; 54(2):227-234.
7. Taina M, Vanninen R, Hedman M, Jäkälä P, Kärkkäinen S, Tapiola T, et al. Left atrial appendage volume increased in more than half of patients with cryptogenic stroke. PLoS ONE. 2013; 8(11):e79519. doi: 10.1371/journal.pone.0079519 PMID: 24223960
8. Sipola P, Hedman M, Onatsu J, Turpeinen A, Halinen M, Jäkälä P, et al. Computed tomography and echocardiography together reveal more high-risk findings than echocardiography alone in the diagnostics of stroke etiology. Cerebrovascular Diseases. 2013; 35(6):521-530. doi: 10.1159/000350734 PMID: 23817231
9. Adams HJ, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. trial of org 10172 in acute stroke treatment. Stroke. 1993; 24(1):35-41.
10. Downing L, Strieter J, Kadell RM, Wilke AM, Austin CA, Hare JC, et al. IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. Journal of Immunology. 1998; 161(3):1471-1476. PMID: 9686613
11. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, et al. Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clinical and Experimental Immunology. 1997; 110(3):492-499. PMID: 9409656
12. Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: Therapeutic approaches. Journal of Translational Medicine. 2009; 7:97. doi: 10.1186/1479-5876-7-97 PMID: 19919699
13. Spera PA, Ellison JA, Feuerstein GZ, Barone FC. IL-10 reduces rat brain injury following focal stroke. Neuroscience Letter. 1998; 251(3):189-192. PMID: 9726375
14. Rodríguez-Yáñez M, Sobrino T, Arias S, Vázquez-Herrero F, Brea D, Blanco M, et al. Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke. Stroke. 2011; 42(10):2813-2818. doi: 10.1161/STROKEAHA.111.614503 PMID: 21836082
15. Strle K, Zhou JH, Shen WH, Broussard SR, Johnson RW, Freund GG, et al. Interleukin-10 in the brain. Critical Reviews of Immunology. 2001; 21(5):427-449. PMID: 11942558
16. Pelidou S, Kostulas N, Matusevicius D, Kivisäkk P, Kostulas V, Link H. High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases. European Journal of Neurology. 1999; 6 (4):437-442.
17. Pepi M, Evangelista A, Nihoyannopoulos P, Flachskampf FA, Athanassopoulos G, Colonna P, et al. (2010) Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 11: 461-476. doi: 10.1093/ejechocard/jeq045 PMID: 20702884
18. Graham TJ, Jarmakani J, Atwood G, Canent RJ. Right ventricular volume determinations in children. normal values and observations with volume or pressure overload. Circulation. 1973; 47:144-153.
19. Emsley H, Smith C, Gavin C, Georgiou RF, Vail A, Barberan EM, et al. Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurology. 2007; 7(1):5.
20. Pelidou SH, Kostulas N, Mutusevicius D, Kivisäkk P, Kostulas V, Link H. High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases. European Journal of Neurology. 1999; 6 (4):437-442.
21. Caligiuri G, Rudling M, Ollivier V, Jacob MP, Michel JB, Hansson GK, et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Molecular Medicine. 2003; 9(1-2):10-17.
22. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, et al. Protective role of interleukin-10 in atherosclerosis. Circulation Research. 1999; 85(8):e17-e24. PMID: 10521249
23. Pinderski OL, Hedrick C, Olvera T, Hagenbaugh A, Territo M, Berliner JA, et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology. 1999; 19 (12):2847-2853. PMID: 10591660
24. van Exel E, Gussekloo J, de Craen A, Bootsma-van der Wiel A, Frölich M, Westendorp R. Inflammation and stroke: The leiden 85-plus study. Stroke. 2002; 33(4):1135-1138. PMID: 11935072
25. Aroor A, McKarns S, Demarco V, Jia G, Sowers J. Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Metabolism. 2013; 62(11):1543-1552. doi: 10.1016/j.metabol.2013.07.001 PMID: 23932846
26. Sahlman J, Miettinen K, Peuhkurinen K, Seppä J, Peltonen M, Herder C, et al. The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea. Journal of Sleep Research. 2010; 19(2):341-348. doi: 10.1111/j.1365-2869.2009.00787.x PMID: 20040038
27. Anguera I, Miranda-Guardiola F, Bosch X, Filella X, Sitges M, Marín JL, et al. Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina. American Heart Journal. 2002; 144(5):811-817. PMID: 12422149
28. Kato K, Oguri M, Hibino T, Yajima K, Matsuo H, Segawa T, et al. Genetic factors for lone atrial fibrillation. International Journal of Molecular Medicine. 2007; 19(6):933-939. PMID: 17487426
29. Heeschen C, Dimmeler S, Hamm C, Fichtlscherer S, Boersma E, Simoons ML, et al. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation. 2003; 107(16):2109-2114. PMID: 12668510
30. Uyemura K, Demer L, Castle S, Jullien D, Berliner JA, Gately MK, et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. The Journal of Clinical Investigation. 1996; 97(9):2130-2138. PMID: 8621803
31. Kilic T, Ural D, Ural E, Yumuk Z, Agacdiken A, Sahin T, et al. Relation between proinflammatory to antiinflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome. Heart. 2006; 92(8):1041-1046. PMID: 16547209
32. Leftheriotis DI, Fountoulaki KT, Flevari PG, Parissis JT, Panou FK, Andreadou KS, et al. The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation. International Journal of Cardiology. 2009; 135(3):361-369.
33. Sikka G, Miller K, Steppan J, Pandey D, Jung SM, Fraser CD 3rd, et al. Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age. Experimental Gerontology. 2013; 48(2):128-135. doi: 10.1016/j.exger.2012.11.001 PMID: 23159957
34. Xie G, Myint P, Zaman M, Li Y, Zhao L, Shi P, et al. Relationship of serum interleukin-10 and its genetic variations with ischemic stroke in a chinese general population. PLoS One. 2013; 8(9):e74126. doi: 10.1371/journal.pone.0074126 PMID: 24040186
35. Jungi T, Brcic M, Eperon S, Albrecht S. Down-regulation of fibrinogen biosynthesis by IL-4, IL-10 and IL-13. Thrombosis Research. 1994; 76(5):463-474. PMID: 7900094
36. Vasse M, Paysant J, Soria J, Mirshahi S, Vannier J, Soria C. Down-regulation of fibrinogen biosynthesis by IL-4, IL-10 and IL-13. British Journal Haematology. 1996; 96(5):955-961.
37. Pajkrt D, van der Poll T, Levi M, Cutler DL, Affrime MB, van den Ende A, et al. Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia. Blood. 1997; 89(8):2701-2705. PMID: 9108387
38. Gudbrandsdottir S, Hasselbalch H, Nielsen C. Activated platelets enhance IL-10 secretion and reduce TNF-a secretion by monocytes. The Journal of Immunology. 2013; 191(8):4059-4067. doi: 10.4049/jimmunol.1201103 PMID: 24048901
39. Hagihara M, Higuchi A, Tamura N, Ueda Y, Hirabayashi K, Ikeda Y, et al. Platelets, after exposure to a high shear stress, induce IL-10-producing, mature dendritic cells in vitro. Journal of Immunology. 2004; 172(9):5297-5303. PMID: 15100268
40. Osmancik P, Paulu P, Tousek P, Kocka V, Widimsky P. High leukocyte count and interleukin 10 predict high on-treatment-platelet-reactivity in patients treated with clopidogrel. Journal of Thrombosis and Thrombolysis. 2012; 33(4):349-354.